SLC33A1 and cancer: Knock‐in mice that lack AT‐1 activity (AT‐1S113R/S113R) die during embryogenesis, while mice with haploinsufficiency of AT‐1 (AT‐1S113R/+) develop neurodegeneration with spasticity and propensity to infections and cancer (Peng et al., 2014).